Apoptosis in the Genesis and Prevention of Cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 1, Issue 7, 1992, Pages 597-602

  Thompson, Henry J ^a   Strange, Robert ^a   Schedin, Pepper J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; COMPARATIVE STUDY; HUMAN; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

APOPTOSIS; COMPARATIVE STUDY; HUMAN; NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026952188     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Weinstein, B. Cancer prevention:recent progress and future opportunities. Cancer Res., 51:5080–5085, 1991.
2. Betram, J. S., Kolonel, L. N., and Meyskens, F. L., Jr. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res., 47:3012–3031, 1987.
3. Boone, C. W., Kelloff, G. J., and Malone, W. E. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials:a review. Cancer Res., 50; 2–9, 1990.
4. Creenwald, P., Nixon, D. W., Malone, W. F., Kelloff, C. J., Stern, H. R., and Witkin, K. M. Concepts in cancer chemoprevention research. Cancer (Phila.) 65:1483–1490, 1990.
5. Wattenberg, L W. Inhibition of carcinogenesis by naturally occurring and synthetic compounds. In:Y. Kuroda, D. M. Shankel, and M. D. Waters (eds.), Antimutagenesis and Anticarcinogenesis, Mechanisms II, pp. 155–166. New York:Plenum Publishing Corp., 1990.
6. Steel, C. G. Growth Kinetics of Tumours. Oxford:Clarendon Press, 1977.
7. Pitot, H. C., and Dragan, Y. P. Facts and theories concerning the mechanisms of carcinogenesis. FASEB J., 5:2280–2286, 1990.
8. Harris, C. C Chemical and physical carcinogenesis:advances and perspectives for the 1990s. Cancer Res., 51:5023–5044, 1991.
9. Sporn, M. B. Carcinogenesis and cancer:different perspectives on the same disease. Cancer Res., 51:6215–6218, 1991.
10. Weinberg R. A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res., 49:3713–3721, 1989.
11. Preston-Martin, S., Pike, M. C., Ross, R. K., Jones, P. A., and Henderson, B. E. Increased cell division as a cause of human cancer. Cancer Res., 50:7415–7421, 1990.
12. Wyllie, A. H. The biology of cell death in tumours. Anticancer Res., 5:131–136, 1985.
13. Wyllie, A. H. Apoptosis:cell death in tissue regulation. J. Pathol., 753. 313–316, 1987.
14. Searle, J., Kerr, J. F. R., and Bishop, C. J. Necrosis and apoptosis:distinct modes of cell death with fundamentally different significance. Pathol. Annu., 17:229–259, 1982.
15. Kerr, J. F. R., Wyllie, A. H., and Currie, A. R. Apoptosis:a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26. 239–257, 1972.
16. Walker, N. I., Bennett, R. E., and Kerr, J. R. Cell death by apoptosis during involution of the lactating breast in mice and rats. Am. J. Anat., 185:19–32, 1989.
17. Strange, R., Li, F., Saurer, S., Burkhardt, A., and Friis, R. R. Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development (Camb.), 115:49–58, 1992.
18. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. Cell death:the significance of apoptosis. Int. Rev. Cytol., 68:251–306, 1980.
19. Walker, N. I., Harmon, B. V., Gobe, G. C., and Kerr, J. F. R. Patterns of cell death. Methods Achiev. Exp. Pathol., 13:18–54, 1988.
20. Bursch, W., Kleine, L., and Tenniswood, M. The biochemistry of cell death by apoptosis. Biochem. Cell Biol., 68:1071–1074, 1990.
21. Trump, B. F., and Berezesky, I. K. Ion regulation, cell injury and carcinogenesis. Carcinogenesis (Lond.), 8:1027–1031, 1987.
22. Wyllie, A. H. Apoptosis:cell death under homeostatic control. Arch. Toxicol. 11 (Suppl.):3–10, 1987.
23. Clarke, P. G. H. Developmental cell death:morphological diversity and multiple mechanisms. Anat. Embryol., 181:195–213, 1990.
24. Bursch, W., Taper, H. S., Lauer, B., and Schulte-Hermann, R. Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows. Arch. B Cell Pathol., 50:153–166, 1985.
25. Bursch, W., Paffe, S., Putz, B., Barthel, G., and Schulte-Hermann, R. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis (Lond.), 11:847–853, 1990.
26. Benedetti, A., Jezequel, A. M., and Orlandi, F. A quantitative evaluation of apoptotic bodies in rat liver. Liver, 8:172–177, 1988.
27. Orrenius, S., McConkey, D. J., and Nicotera, P. Role of calcium in toxic and programmed cell death. Adv. Exp. Biol. Med., 283:419–425, 1991.
28. Arends, M. J., Morris, R. C., and Wyllie, A. H. Apoptosis. The role of the endonuclease. Am. J. Pathol., 136; 593–608, 1990.
29. McConkey, D. J., Hartzeil, P., Nicotera, P., and Orrenius, S. Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J., 3:1843–1849, 1989.
30. Kizaki, H., Tadakuma, T., Odaka, C., Muramatsu, J., and Ishimura, Y. Activation of a suicide process of thymocytes through DNA fragmentation by calcium ionophores and phorbol esters. J. Immunol., 143:1790–1794, 1989.
31. Stanbridge, E. J. Human tumor suppressor genes. Annu. Rev. Genet., 24. 615–657, 1990.
32. Boyd, J. A., and Barrett, J. C. Tumor suppressor genes:possible functions in the negative regulation of cell proliferation. Mol. Carcinog., 3:325–329, 1990.
33. Bouck, N. Tumor angiogenesis:the role of oncogenes and tumor suppressor genes. Cancer Cells (Cold Spring Harbor), 2:179–185, 1990.
34. Schulte-Hermann, R., Timmermann-Trosiener, I., Barthel, C., and Bursch, W. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phénobarbital promotion. Cancer Res., 50:5127–5135, 1990.
35. Columbano, A., Ledda-Columbano, C. M., Rao, P. M., Rajalakshmi, S., and Sarma, D. S. R. Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. Am. J. Pathol., 116:441–446, 1984.
36. Columbano, A., Ledda-Columbano, G. M., Rao, P. M., Rajalakshmi, S., and Sarma, D. S. R. Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. Am. J. Pathol., 116:441–446, 1984.
37. Ucker, D. S. Death by suicide:one way to go in mammalian cellular development? New Biol., 3:103–109, 1991.
38. Gullino, P. M. The regression process in hormone-dependent mammary carcinomas. Prog. Cancer Res. Ther., 14:271–279, 1980.
39. Cotter, T. G., Lennon, S. V., Glynn, J. G., and Martin, S. J. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells. Anticancer Res., 10:1153–1160, 1990.
40. Williams, G. T. Programmed cell death:apoptosis cell oncogenesis. Cell, 65:1097–1098, 1991.
41. Russo, I. H., Koszalka, M., and Russo, J. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br. J. Cancer, 64:481–484, 1991.
42. Grubbs, C. J., Peckham, J. C., and McDonough, K. D. Effect of ovarian hormones on the induction of 1-methyl-1-nitrosourea-induced mammary cancer. Carcinogenesis (Lond.), 4:495–497, 1983.
43. Thompson, H. J., Becci, P. J., Brown, C. C., and Moon, R. C. Effect of the duration of retinyl acetate feeding on inhibition of 1-methyl-1-nitrosourea-induced mammary carcinogenesis in the rat. Cancer Res., 39; 3977–3980, 1979.
44. Ip, C., and Thompson, H. J. New approaches to cancer chemoprevention with difluoromethylornithine and selenite. J. Natl. Cancer Inst. 81:839–843, 1989.
45. Lennon, S. V., Martin, S. J., and Cotter, T. G. Induction of apoptosis (programmed cell death) in tumour cell lines by widely diverging stimuli. Biochem. Soc. Trans., 18:343–345, 1990.
46. Bandyk, M. G., Sawczuk, I. S., Olsson, C. A., Katz, A. E., and Buttyan, R. Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury. J. Urol., 143:407–413, 1990.
47. Kyprianou, N., English, H. F., Davidson, N. E., and Isaacs, J. T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res., 51:162–166, 1991.
48. Kyprianou, N., and Isaacs, J. T. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology, 122:552–562, 1988.
49. Kyprianou, N., Alexander, R. B., and Isaacs, J. T. Activation of programmed cell death by recombinant human tumor necrosis factor plus topoisomerase ll-targeted drugs in L929 tumor cells. J. Natl. Cancer Inst. 83:346–350, 1991.
50. Thompson, H. J., Meeker, L. D., Herbst, E. J., Ronan, A. M., and Minocha, R. Effect of concentration of o, L-2-difluoromethylornithine on murine mammary carcinogenesis. Cancer Res., 45:1170–1173, 1985.
51. Jordon, V. C., and Chem, F. C. Laboratory studies to develop general principles for the adjuvant treatment of breast cane er with antiestrogens:problems and potential for future clinical applications. Breast Cancer Res. Treat., 3 (Suppl. 1). 73–86, 1983.